Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 510.00
Bid: 0.00
Ask: 547.00
Change: 0.00 (0.00%)
Spread: 37.00 (7.255%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 510.00
CRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

3 Feb 2009 07:00

RNS Number : 6484M
Creston PLC
03 February 2009
 



3 February 2009

Creston plc 

Interim Management Statement 

Creston plc (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 April 2008 to 2 February 2009.

Financial Performance Indicators

Trading for the nine months ending December 2008 have been in line with the Board's expectations and demonstrate growth during a difficult economic environment:

Revenue growth of 4%

Headline operating profit margin after head office costs of 18% (2008: 18%) 

Operating cash conversion from EBITDA of 97 percent. 

Headline performance measures exclude the impact of the non-recurring charges outlined in the Company's Interim statement.

New Business

In the Interim statement for the six months ending September 2008, the Group announced net new business revenue annualised at £11m (2008: £5m). This excellent new business performance has continued to date with further wins across both Divisions, which include Boehringer Ingelheim, COI (Stroke Awareness), Unilever (Lynx), Services at Home, Spicers and Xchanging. As the new calendar year starts, there continues to be a good pipe line of new business opportunities across the Group and recent wins that will be announced shortly.

Operational Trading

The Board's business objectives remain unchanged with a focus on reducing debt and maintaining upper quartile key performance indicators (KPIs), such as revenue per head, operating profit margin and cash conversion. As noted above the cash conversion on EBITDA for the nine months has been good and the reduction in net debt remains in line with the Board's expectations.

As reported in the Group's Interim statement, only 21 per cent of the Group's revenue is in advertising and over 70 per cent in direct and digital marketing, healthcare marketing and market research. This diversification towards more resilient areas of the marketing industry has benefited the Group as demonstrated in the financial performance noted above.

The Communications Division has benefited from its weighting towards direct and digital marketing and offering integrated on and off line communication. This Division continues to achieve strong year on year growth driven by an excellent new business performance.

Trading for the Insight Division continues to be robust in the larger companies ICM and Marketing Sciences. However, as reported in the Interims the niche discipline of qualitative market research continues to experience a year-on-year decline and the Company has taken the necessary steps to align costs and structure to the trading outlook.

Outlook

The Board is realistic about the tough trading environment the UK economy faces and as the Group prepares for the new financial year, it will reduce its operating cost base where necessary, so its KPIs remain in line. Based on the nine month trading performance to the end of December 2008, the Group remains on course to meet the Board's expectations for the current financial year

For further information, please contact:

Creston plc

020 7930 9757

Don Elgie, Chief Executive

Barrie Brien, COO/CFO

www.creston.com 

Hogarth Partnership Limited

020 7357 9477

Chris Matthews/Anthony Arthur/ Fiona Noblet

 

About Creston plc

Creston is an Insight and Communications marketing services group. The Board's aim is to identify synergistic benefits between its marketing services companies offering premium services such as market research, direct and interactive marketing, advertising, public relations, insight; and to build a Group that offers effective and accountable marketing solutions across both on-line and off-line channels. 

Creston's companies boast a range of blue-chip clients including the Amazon, AstraZeneca, Bayer, BMW, BT, Burger King, Canon, COI Communications, Cow & Gate, Daily Mirror, Diageo, eBay, First Direct, General Motors, GlaxoSmithKline, Halifax, Homeform, House of Fraser, Kimberly-Clark, Lexus, Lloyds Black Horse, Morrisons, NHS Lottery, Nissan, Norwich Union, Pfizer, Roche DiagnosticsRoyal Mail, SAB Miller, Sainsbury's, Tesco, Thorpe Park, Toshiba, Trinity Mirror, T-Mobile, Tropicana, Unilever, Vodafone, Walkers and WH Smith.

Creston's share price is quoted in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEALAAELXNEFE
Date   Source Headline
27th Apr 20225:15 pmRNSNotice of Q1 2022 Trading Update / Conference Call
25th Apr 20221:51 pmRNSTransaction in Own Shares
22nd Apr 20229:08 amRNSTransaction in Own Shares
12th Apr 20225:15 pmRNS2022 Notice of Annual General Meeting
12th Apr 20227:05 amRNSTransactions in own shares
12th Apr 20227:00 amRNSNotification of major holdings
30th Mar 20226:20 pmRNSPublication of 2021 Annual Report & Accounts
24th Mar 20225:36 pmRNSPDMR notification
22nd Mar 20226:14 pmRNSTransactions in own shares
22nd Mar 20226:08 pmRNSTransactions in own shares - CORRECTION
22nd Mar 20222:10 pmRNSNotification of major holdings
18th Mar 20222:59 pmRNSPDMR Notification
18th Mar 202211:52 amRNSTransaction in Own Shares
17th Mar 20229:03 amRNSTransactions in own shares
15th Mar 20225:10 pmRNSDirector/PDMR Shareholding
9th Mar 20222:45 pmRNSPDMR Notification
9th Mar 20222:45 pmRNSPDMR Notification
9th Mar 20221:33 pmRNSTransaction in Own Shares
8th Mar 20228:33 amRNSTransactions in own Shares
7th Mar 20225:45 pmRNSPDMR Notification
7th Mar 20221:32 pmRNSTransaction in Own Shares
4th Mar 20223:16 pmRNSNotification of major holdings
4th Mar 20221:48 pmRNSTransaction in Own Shares
3rd Mar 202212:54 pmRNSTransactions in own shares
2nd Mar 20222:14 pmRNSTransaction in Own Shares
1st Mar 20222:02 pmRNSTransactions in own shares
28th Feb 20221:06 pmRNSTransaction in Own Shares
25th Feb 20225:49 pmRNSTransactions in own shares
24th Feb 20227:00 amRNSConduit Holdings Limited 2021 Preliminary Results
21st Feb 20221:30 pmRNSTransaction in Own Shares
21st Feb 202212:56 pmRNSReplacement - Notice of Preliminary 2021 Results
17th Feb 20227:00 amRNSNotice of Preliminary 2021 Results
16th Feb 20227:01 amRNSTransactions in own shares
16th Feb 20227:00 amRNSDirector/PDMR Shareholdings - Correction
16th Feb 20227:00 amRNSTransaction in Own Shares
15th Feb 202211:34 amRNSAppointment of Chief Underwriting Officer
10th Feb 20222:46 pmRNSTR-1: Notification of major holdings
9th Feb 20223:06 pmRNSTR-1: Notification of major holdings
7th Feb 20227:00 amRNSHolding(s) in Company
19th Jan 20227:00 amRNSConduit Holdings Ltd January 2022 Trading Update
13th Jan 20228:51 amRNSNotice of Trading Statement and Conference Call
31st Dec 20217:00 amRNSTransaction in Own Shares
29th Dec 20217:00 amRNSShare Purchase for Variable Incentive Schemes
16th Dec 20212:50 pmRNSA.M. Best affirms Conduit Reinsurance's ratings
3rd Dec 20217:00 amRNSPDMR notification
30th Nov 20212:09 pmRNSDirector/PDMR Shareholding
24th Nov 20213:58 pmRNSPDMR Notification
19th Nov 202112:59 pmRNSPDMR Notification
15th Nov 202111:44 amRNSDirector/PDMR Shareholding
9th Nov 20217:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.